Abstract Details

Title Treatment Optimization Recommendations Can Predict Deterioration in MS Patients

Topic MS and Related Diseases

Presentation(s) (-)

Poster/Presentation
Number 162

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Juan Luis Ruiz Pena, MD (SERVICIO ANDALUZ SALUD)	No disclosure on file
Guillermo Izquierdo Ayuso, MD (Servicio De Neurologia)	Dr. Izquierdo Ayuso has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer, Biogen Idec, Novartis, Sanofi, Merck Serono, Roche, Actelion and Celgene. Dr. Izquierdo Ayuso has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genzyme, Novartis, Sanofi Aventis, Alexion.
Kelsey R. Barrell, MD	Dr. Juster-Switlyk has nothing to disclose.

��ɫ����